Evaluation of efficacy and safety profile of posaconazole for prophylaxis after allogeneic haematopoietic stem cell transplant

被引：0
|
作者：
Silva, F. [1 ]
Vazquez, L. [1 ]
Morales, E. [1 ]
Caballero, D. [1 ]
Perez-Simon, J. A. [1 ]
Sanchez-Guijo, F. [1 ]
del Canizo, C. [1 ]
Miguel, J. San [1 ]
机构：
[1] Hosp Univ Salamanca, Salamanca, Spain
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [41] Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study
    Stern, Anat
    Henig, Israel
    Cohen, Maya
    Gur, Ivan
    Henig, Oryan
    Zuckerman, Tsila
    Paul, Mical
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (12) : 3289 - 3296
  • [42] Efficacy and safety of therapeutic phlebotomy for iron overload in allogeneic haematopoietic stem cell transplantation recipients
    Mohty, B.
    Chok, L.
    Casini, A.
    Grandjean, A-P
    Masouridi, S.
    Lambert, J. F.
    Helg, C.
    Stalder, M.
    Voegeli, J.
    Starobinski, M.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S344 - S345
  • [43] Mucormycosis after allogeneic haematopoietic stem cell transplantation
    Clement, L
    Salmon, A
    Mansuy, L
    Paczesny, S
    Bordigoni, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S205 - S205
  • [44] Safety of Posaconazole and Sirolimus Coadministration in Allogeneic Hematopoietic Stem Cell Transplants
    Kubiak, David W.
    Koo, Sophia
    Hammond, Sarah P.
    Armand, Philippe
    Baden, Lindsey R.
    Antin, Joseph H.
    Marty, Francisco M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (09) : 1462 - 1465
  • [45] Conjunctival T cell profile after instilling Topical Cyclosporine-A 0.1% cationic emulsion in Allogeneic Haematopoietic Stem Cell Transplant patients
    Lim, Elizabeth
    Tong, Louis
    Yeo, Sharon
    Hou, Aihua
    Lim, Li
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [46] Posaconazole in paediatric malignancy and haematopoietic stem cell transplant: dosing to achieve therapeutic concentration
    Weerdenburg, Heather
    Walker, Hannah
    Curtis, Nigel
    Duffull, Stephen
    Haeusler, Gabrielle
    Cole, Theresa
    Gwee, Amanda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (07) : 1493 - 1507
  • [47] Efficacy and safety of micafungin for antifungal prophylaxis in patients receiving allogeneic stem cell transplantation
    Santarone, S.
    Olioso, P.
    Natale, A.
    Papalinetti, G.
    Bonfini, T.
    Accorsi, P.
    Angelini, S.
    Parruti, G.
    Di Bartolomeo, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S404 - S405
  • [48] Primary antifungal prophylaxis with posaconazole vs fluconazole in early neutropenic phase after allogeneic stem cell transplantation
    Mele, A.
    Greco, G.
    De Risi, C.
    Sibilla, S.
    Rossini, B.
    Carlino, D.
    Citiso, S.
    Prete, E.
    Morciano, M. R.
    Peluso, A.
    Pavone, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S582 - S583
  • [49] Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation
    Heinz, Werner J.
    Stanchi, Karin M. Cabanillas
    Klinker, Hartwig
    Blume, Olivia
    Feucht, Judith
    Hartmann, Ulrike
    Feuchtinger, Tobias
    Lang, Peter
    Handgretinger, Rupert
    Doering, Michaela
    MEDICAL MYCOLOGY, 2016, 54 (02) : 128 - 137
  • [50] Posaconazole has superior clinical efficacy and cost-effectiveness to itraconazole for antifungal prophylaxis in allogeneic stem cell transplant recipients: a single-centre experience
    Duarte, R. F.
    Patino, B.
    Munoz, C.
    Arnan, M.
    Peralta, T.
    Gudiol, C.
    Sanchez-Ortega, I.
    Parody, R.
    Clopes, A.
    Lopez-Belmonte, J. L.
    Sabater, F. J.
    de Sevilla, A. Fernandez
    BONE MARROW TRANSPLANTATION, 2009, 43 : S258 - S258
12345